Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Frontiers in Immunology
|
October 31, 2018
Regulatory T Cells in Systemic Sclerosis
Camelia Frantz, Cedric Auffray, Jerome Avouac, et al.
Disease Markers
|
May 29, 2018
Soluble CD163 as a Potential Biomarker in Systemic Sclerosis
Camelia Frantz, Sonia Pezet, Jerome Avouac, et al.
La Revue De Medecine Interne
|
July 9, 2026
[Pasteurella multocida septic arthritis in a native joint: Management dilemmas in a penicillin-allergic patient]
Jeanne Chevalier, Margot Guedot, Camelia Frantz, et al.
Clinical and Experimental Rheumatology
|
May 3, 2021
Risk of liver fibrosis induced by methotrexate and other rheumatoid arthritis medications according to the Fibrosis-4 Index
Jérôme Avouac, Raphael Degrave, Helene Vergneault, et al.
Arthritis Research & Therapy
|
May 31, 2015
Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis
Nadira Ruzehaji, Jerome Avouac, Muriel Elhai, et al.
Arthritis Research & Therapy
|
November 14, 2023
Retraction Note: Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis
Nadira Ruzehaji, Jerome Avouac, Muriel Elhai, et al.
Journal of Scleroderma and Related Disorders
|
February 9, 2024
Deficiency and altered phenotype of mucosal-associated invariant T cells in systemic sclerosis
Manon Lesturgie-Talarek, Virginie Gonzalez, Lucie Beaudoin, et al.
Seminars in Arthritis and Rheumatism
|
May 3, 2016
Impaired quality of life in systemic sclerosis and patient perception of the disease: A large international survey
Camelia Frantz, Jérôme Avouac, Oliver Distler, et al.
Annals of the Rheumatic Diseases
|
March 11, 2016
Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis
Nadira Ruzehaji, Camelia Frantz, Matthieu Ponsoye, et al.
Joint Bone Spine
|
December 27, 2022
Risk stratification using anti-citrullinated peptide antibodies (ACPA) in polyarticular subtypes of juvenile idiopathic arthritis in adulthood
Alice Combier, Camelia Frantz, Julien Wipff, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Frontiers in Immunology
|
October 31, 2018
Regulatory T Cells in Systemic Sclerosis
Camelia Frantz, Cedric Auffray, Jerome Avouac, et al.
Disease Markers
|
May 29, 2018
Soluble CD163 as a Potential Biomarker in Systemic Sclerosis
Camelia Frantz, Sonia Pezet, Jerome Avouac, et al.
La Revue De Medecine Interne
|
July 9, 2026
[Pasteurella multocida septic arthritis in a native joint: Management dilemmas in a penicillin-allergic patient]
Jeanne Chevalier, Margot Guedot, Camelia Frantz, et al.
Clinical and Experimental Rheumatology
|
May 3, 2021
Risk of liver fibrosis induced by methotrexate and other rheumatoid arthritis medications according to the Fibrosis-4 Index
Jérôme Avouac, Raphael Degrave, Helene Vergneault, et al.
Arthritis Research & Therapy
|
May 31, 2015
Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis
Nadira Ruzehaji, Jerome Avouac, Muriel Elhai, et al.
Arthritis Research & Therapy
|
November 14, 2023
Retraction Note: Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis
Nadira Ruzehaji, Jerome Avouac, Muriel Elhai, et al.
Journal of Scleroderma and Related Disorders
|
February 9, 2024
Deficiency and altered phenotype of mucosal-associated invariant T cells in systemic sclerosis
Manon Lesturgie-Talarek, Virginie Gonzalez, Lucie Beaudoin, et al.
Seminars in Arthritis and Rheumatism
|
May 3, 2016
Impaired quality of life in systemic sclerosis and patient perception of the disease: A large international survey
Camelia Frantz, Jérôme Avouac, Oliver Distler, et al.
Annals of the Rheumatic Diseases
|
March 11, 2016
Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis
Nadira Ruzehaji, Camelia Frantz, Matthieu Ponsoye, et al.
Joint Bone Spine
|
December 27, 2022
Risk stratification using anti-citrullinated peptide antibodies (ACPA) in polyarticular subtypes of juvenile idiopathic arthritis in adulthood
Alice Combier, Camelia Frantz, Julien Wipff, et al.
Page
of 2